XML 71 R54.htm IDEA: XBRL DOCUMENT v3.7.0.1
SHARE-BASED COMPENSATION PLANS (Tables)
 12 Months Ended
Jun. 30, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Fair value valuation assumptions
As of June 30, 2017, the fair value of the Company’s outstanding Series A Preferred Stock that are liability accounted were estimated with the following weighted-average assumptions.
 
2017
Expected life, in years
5.86 years
Expected volatility
30.00%
Risk-free rate of return
1.99%
Dividend yield on Class A Common Stock
2.67%
Yield on cash
4.70%
The fair value of the Company’s outstanding Series A Preferred Stock liability on June 30, 2016 and 2015 was estimated using the Black-Scholes valuation model with the following assumptions:
 
2016
 
2015
Expected life
4.79 years
 
5.79 years
Risk-free interest rate
1.01%
 
1.96%
Expected volatility
36.74%
 
26.14%
Expected dividend yield
0.96%
 
0.63%
During fiscal 2017, 2016 and 2015, the share-based compensation expense recognized on nonqualified stock options is based upon the fair value on the grant date estimated using the Black-Scholes valuation model with the following weighted-average assumptions:
 
2017
 
2015
Expected life
7.50 years
 
7.50 years
Risk-free interest rate
1.60%
 
1.79%
Expected volatility
36.74%
 
31.73%
Expected dividend yield
1.62%
 
0.80%
Outstanding nonqualified stock option activity
The Company’s outstanding nonqualified stock options as of June 30, 2017 and activity during the fiscal year then ended are presented below:
 
Shares
(in millions)
 
Weighted
Average
Exercise
Price
 
Aggregate
Intrinsic
Value
 
Weighted
Average
Remaining
Contractual
Term (in years)
Outstanding at July 1, 2016
7.3

 
$
11.25

 
 
 
 
Granted
9.3

 
18.61

 
 
 
 
Exercised
(2.2
)
 
9.71

 
 
 
 
Forfeited
(2.4
)
 
19.31

 
 
 
 
Outstanding at June 30, 2017
12.0

 
$
15.64

 
 
 
 
Vested and expected to vest at June 30, 2017
9.4

 
$
14.98

 
$
35.5

 
6.83
Exercisable at June 30, 2017
4.0

 
$
9.74

 
$
36.2

 
3.10
A summary of the total intrinsic value of stock options exercised and payments to settle nonqualified stock options
A summary of the aggregated weighted-average grant date fair value of stock options granted, total intrinsic value of stock options exercised and payment to settle nonqualified stock options for fiscal 2017, 2016 and 2015 is presented below:
 
2017
 
2016
 
2015
Weighted-average grant date fair value of stock options
$
6.34

 
$
—

 
$
8.75

Intrinsic value of options exercised
26.30

 
87.60

 
77.20

Payment to settle nonqualified stock options of former CEOs
—

 
—

 
12.00
Scheduled of outstanding Series A Preferred shares
The Company’s outstanding Series A Preferred Shares as of June 30, 2017 and activity during the fiscal year then ended are presented below:
 
Shares
(in millions)
 
Weighted
Average
Exercise Price
 
Aggregate Intrinsic Value
 
Weighted Average Remaining Contractual Term (in years)
Outstanding at July 1, 2016
1.7

 
$
27.97

 
 
 
 
Granted
2.5

 
22.42

 
 
 
 
Outstanding at June 30, 2017
4.2

 
$
24.66

 
 
 
 
Vested and expected to vest at June 30, 2017
3.7

 
$
24.57

 
$
—

 
5.90
Schedule of non-vested nonqualified share activity
The Company’s non-vested nonqualified stock options as of June 30, 2017 and activity during the fiscal year then ended are presented below:
 
Shares
(in millions)
 
Weighted
Average
Grant Date
Fair Value
Non-vested at July 1, 2016
4.4

 
$
4.81

Granted
9.3

 
18.61

Vested
(3.3
)
 
3.99

Forfeited
(2.4
)
 
6.87

Non-vested at June 30, 2017
8.0

 
$
6.33

The Company’s non-vested shares of Series A Preferred Stock as of June 30, 2017 and activity during the fiscal year then ended are presented below:
 
Shares
(in millions)
 
Weighted
Average
Grant Date
Fair Value
Non-vested at July 1, 2016
1.7

 
$
5.24

Granted
2.5

 
4.53

Vested
(1.0
)
 
3.63

Non-vested at June 30, 2017
3.2

 
$
5.19
Outstanding RSU activity
The Company’s outstanding RSUs as of June 30, 2017 and activity during the fiscal year then ended are presented below:
 
Shares
(in millions)
 
Aggregate
Intrinsic
Value
 
Weighted
Average
Remaining
Contractual
Term
Outstanding at July 1, 2016
4.2

 
 
 
 
Granted
2.8

 
 
 
 
Settled
(0.2
)
 
 
 
 
Cancelled
(1.2
)
 
 
 
 
Outstanding at June 30, 2017
5.6

 
 
 
 
Vested and expected to vest at June 30, 2017
4.6

 
$
85.9

 
2.75
Outstanding and non-vested RSU activity
The Company’s outstanding and non-vested RSUs as of June 30, 2017 and activity during the fiscal year then ended are presented below:
 
Shares
(in millions)
 
Weighted
Average
Grant Date
Fair Value
Outstanding and nonvested at July 1, 2016
3.9

 
$
19.75

Granted
2.8

 
24.56

Vested
(0.2
)
 
15.63

Cancelled
(1.2
)
 
19.45

Outstanding and nonvested at June 30, 2017
5.3

 
$
21.76